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Teaching physicians about different measures 
of risk reduction may alter their treatment 
preference 
We explored during a postgraduate workshop whether basic teaching 
about absolute and relative effect measures changed physicians" per- 
ceptions of the benefit to be derived from modifying particular cardio- 
vascular risk factors. Before and after instruction physicians were asked 
about the priority th~ey would give to interventions to reduce four risk 
factors of coronary fieart disease in two mate patients, aged 35 and 65 
years with multiple risk factors. They were given information about the 
relative risk (RR), absolute risk reduction (ARR) and the number of pa- 
tients who need to be treated (NNT): to prevent one event associated 
with the modification of each risk factor. Ratings of 48 of the 67 participat- 
ing physicians (71.6%) were evaluated. About half did not change their 
choices regarding the benefit from a particular intervention. Among 
those who changed, :the new choice was in favor of the patient with 
the higher ARR for three risk factors (hypertension, p = 0.0 I; smoking, 
p=O 002; non-insulin-dependent diabetes, p=0.05) but not the fourth 
(left ventricular hxl3ertrophy, p= O. 82). Teaching basic principles of clini- 
ca• epiderniology to physicians can have an tmpact on their perception of 
treatment effects. However, this will not suffice in itself to guarantee 
that this new knowledge will become part of their clinical practice. 
The results of a clinical trial may 
be expressed in various ways. For 
example, R1 is the risk for the 
studied outcome in the treated 
group and R 0 is the risk in the 
placebo group, it has been shown 
that physicians are inclined to 
interpret he results as being more 
favorable when they are expressed 
as relative risk (RR = Ro: R1) rath- 
er than absolute risk difference 
(ARR = Ro-R1) 1-7. The number of 
patients who need to be treated in 
order to prevent one event (NNT) 8 
is an additional, very intuitive mea- 
sure of absolute risk reduction 
(NNT = 1: (Ro-R1)) that does not 
yet belong to the interpretation 
skills of most clinicians. 
Basic principles about how to ob- 
tain information on RR, ARR and 
NNT from clinical trials have been 
published 9,1~ but little is known 
about whether these principles are 
used by clinicians. During a post- 
graduate workshop in continuing 
medical education we investigated 
to what extent physicians who have 
been taught how to compute and 
interpret RR, ARR and NNT are 
likely to take these effect measures 
into account when making treat- 
ment decisions. 
Methods 
A workshop about basic principles 
of clinical epidemiology was given 
during a postgraduate course for 
continuing medical education offer- 
ed in 1995 by the Swiss Society of 
Internal Medicine. The majority of 
the 67 physicians who attended the 
workshop were general internists 
(51.8%) and working in private 
practice (54.7 % ). Of those working 
in the hospital (n = 28), 67.9 % were 
residents, 14.3 % were senior resi- 
dents and 17.9% were staff mem- 
bers. Mean age was 44.8 (SD= 
11.2). Mean time since graduation 
from medical school was 18.4 years 
(SD = 11.4). Physicians were divid- 
ed in three one-hour sessions of 
equal sizes. The language was 
German in two sessions and French 
in the other. 
Before the lecture, the participants 
were given a small questionnaire 
(See appendix) about two male 
patients aged 35 and 65 years with 
identical risk factors for coronary 
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heart disease: systolic blood pres- 
sure of 165 mmHg, smoking 15 
cigarettes per day, non-insulin- 
dependent diabetes and left ventri- 
cular hypertrophy on ECG. Using 
the Framingham risk profile score 
for incidence of coronary heart 
disease 11 we showed for both pa- 
tients the RR, the corresponding 
absoute risk reduction and the 
number needed to treat over 6 
years for the following modifica- 
tions of risk factors: reduction of 
systolic blood pressure to 120 mm 
Hg, cessation of smoking, normal- 
ization of glucose intolerance, and 
normalization of left ventricular 
hypertrophy. Physicians were asked 
to rate which of the two patients 
would benefit most from a given 
risk factor modification. 
After having completed the ques- 
tionnaire physicians were given 
30 minutes instruction given by the 
two authors. The concepts of risk, 
RR, ARR and NNT were explain- 
ed and illustrated with two ex- 
amples 12,13. Advantages and disad- 
vantages of these effect measures 
were explained. 
This instruction was followed by a 
second questionaire (See Appen- 
dix) with a slightly different ex- 
ample of two male patients aged 35 
and 65 with similar multiple risk 
factors for coronary heart disease. 
Again physicians were asked to 
rate which patient would benefit 
the most from the following 
risk factor modifications: reduction 
of systolic blood pressure from 
145mmHg to normal, smoking 
cessation i a smoker who consum- 
ed 15 cigarettes per day, normal- 
ization of blood sugar in non- 
insulin-dependent diabetes and 
modification of left ventricular 
hypertrophy. All three effect mea- 
sures were similar to those in the 
first example. 
We estimated the impact of our 
teaching program as follows. For 
each risk factor modification, the 
number of physicians who changed 
their assignment of the higher 
benefit from intervention i favor 
of the patient with the higher 
ARR was compared using the 
McNemar chi square test with the 
number of physicians who changed 
their assignment not in favor of 
the patient with the higher ARR. 
Complete questionnaires which 
allowed paired analysis were 
obtained from 48 of the physicians. 
Statistical analysis was done with 
the SAS package for personal 
computers 14. 
Results 
Table 1 shows that, after the short 
instruction, about half of the phy- 
sicians did not change their assign- 
ment of the patient who would 
benefit most from a given interven- 
tion. However, among those who 
changed, the new choice was in 
favor of the patient for whom the 
ARR was higher for three of the 
four risk factors. For hypertension 
18 physicians changed their assign- 
ment in favor of the patient with 
the higher ARR and 5 in favor 
of another option (higher RR or 
similar benefit in both patients) 
(p=0.01). These numbers were, 
respectively, 22 and 5 for smoking 
(p=0.002); 11 and 9 for left ven- 
tricular hypertrophy (p= 0.82), and 
16 and 6 for non-insulin-dependent 
diabetes (p = 0.5). 
Discussion 
This study suggests that a short 
period of instruction on basic prin- 
ciples of clinical epidemiology 7,9
may sensitize some physicians 
about how to interpret different 
effect measures and how this 
information can be integrated 
into clinical decision making. How- 
ever, changes in decisions occur- 
red in only half of the physicians, 
and for another 10 to 20% the 
change in preference was not in 
favor of the patient with the higher 
ARR. 
8 
favor of 
/o no 
hange 
52 
43 
57 
51 
Table I. Physicians" treatment preference for modifying 4 cardiovascular isk factors prior to and after instruction 
on basic principles for assessing effect measures. 
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Before the instruction, roughly one 
third of the physicians gave their 
treatment preference to the patient 
with the higher ARR from cardio- 
vascular risk factor modification. 
After the instruction, when two 
patients with similar multiple risk 
factors for coronary heart disease 
were presented, the physicians 
were more inclined to give treat- 
ment to the patient with the higher 
attributable risk reduction from 
intervention priority in the case of 
three of the four presented risk 
factor modifications. No signifi- 
cant change in treatment pre- 
ference was found for the treat- 
ment of left ventricular hyper- 
trophy. A reason for this finding 
could be that in the presence of 
organ damage, and in view of the 
moderate possibility for its modifi- 
cation, physicians had more dif- 
ficulty in giving treatment priority 
to either patient. 
Future investigations on the impact 
of teaching clinicians about epi- 
demiological principles of clinical 
effect measures could benefit from 
taking into consideration the limi- 
tations of the present study. First, 
the measure of effects given in 
the questionnaires were computed 
using the Framingham risk profile. 
This model may not be the optimal 
because it gives six-year risks of 
coronary heart disease and there- 
fore does not reflect the fact that 
the remaining life span was higher 
for the younger subject. In addi- 
tion, the Framingham risk profile is 
limited to coronary heart disease 
and does not consider for any other 
benefit of smoking cessation. 
Secondly, the sample comprised 
motivated physicians, convinced 
that attending our workshop would 
be worthwhile and may therefore 
not have been representative of the 
majority of Swiss physicians. Final- 
ly, a short period of instruction may 
generate confusion in a minority of 
participants. 
In summary, teaching basic prin- 
ciples of clinical epidemiology and 
evidence based medicine to physi- 
cians can have an impact on phy- 
sicians' perceptions of treatment ef- 
fects. However, for most of them, 
this will not suffice in itself to 
guarantee that this new knowledge 
will become part of their clinical 
practice. 
Zusammenfassung 
duktion kann 
Wir untersuchten in einem Weiterbildungskurs for praktizierende /~rzte, 
inwiefem die Vermittlung yon Grundkenntnissen von relativen und ab- 
soluten Wirkgrdssen die Beurteilung der Wirksamkeit kardiovaskul~rer 
Risikofaktorenmodifikation ver~ndert. /~rzte gaben vor und nach einem 
theoretischen Kurs zu 4 Risikofaktoren ihre Behandlungspraferenzen bei 
/e einem 35- und 55j&hrigen mannfichen Patienten mit multiplen Risiko- 
faktoren an. FOr jede Behandlungssituation lagen die Angaben in rela- 
tiven und absoluten Risiken sowie die Anzahl zu Behandelnder pro ver- 
hOtetem Krankheitsereignis vor. Fragebogen von 48 (71,6%) Teilneh- 
mem (n = 67) waren verwertbar. Rund die H~lfte der Teilnehmer ander- 
ten in den Angaben nach Kursinstruktion ihre Behandlungspraferenz 
nicht. /~rzte, wetche ihre Behandlungspraferenz anderten, gaben nach 
Intervention bei drei Risikofaktoren (Hypertonie, p=O.01; Rauchen, 
p=O.O02; nicht insulinpflichtiger Diabetes mellitus, p=O.O05), jedoch 
nicht bei der Behandlung der linksventrikul~ren Hypertrophie (p= 0.82) 
ihre Behandlungspr~ferenz dem Patienten mit der h6heren absoluten 
Risikoreduktion. Die vermittlung von Prinzipien der klinischen Epidemio- 
kann die Beurteilung von Behandlungseffekten andern. Inwieweit 
es Wissen in die praktische Entscheidungsfindung Eingang findet, 
uss in weiteren Studien evaluiert werden. 
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Appendix 
Questionnaire I
We present he examples of two 
men having similar risk factors for 
coronary heart disease. The first 
man is 35 years old. The second 
man is 65 years old. Both men have 
the following risk factors for 
coronary heart disease: Systolic 
blood pressure 165mmHg, both 
men smoke 15 cigarettes a day, 
have a non-insulin dependent dia- 
betes and show left ventricular 
hypertrophy in the ECG. 
Using the Framingham risk profile 
for coronary heart disease we have 
computed the relative risk, the 
absolute risk reduction and the 
number needed to be treated over 
6 years associated with modifying 
each of these risk factors, that is, 
reduction of systolic blood pres- 
sure to 120mmHg, smoking ces- 
sation, normalisation of glucose 
intolerance and left ventricular 
hypertrophy. 
For each risk factor indicate in the 
last column of the table which pa- 
tient would benefit most from a 
risk factor modification. 
Risk fact6r Subject 1 
5 years old 
)solute 
~k 
~duction 
number 
needed 
to treat 
Subject 2 
65 years old 
relative absolute 
risk risk 
reduction 
0.6 -4 1 
0.7 -3.4 
0.5 -5.1 
0.8 -2.2 
~1:10 100 
.:0:8 125 
~1.2 83 
-0:5 2oo 
atment of 1000 patients for 6 years. 
Treat in priority 
subject I or 2 
number 
needed 
to treat 
43 
29 
20 
45 
71 
: i  84 ~ : ::=- : ! i :  : : 
Questionnaire II 
We present he examples of two 
men having similar risk factors for 
coronary heart disease. The first 
man is 35 years old. The second 
man is 65 years old. Both men have 
the following risk factors for coro- 
nary heart disease: Systolic blood 
pressure 145mmHg, both men 
smoke 15 cigarettes a day, have a 
non-insulin dependent diabetes 
and show left ventricular hypertro- 
phy in the ECG. 
Using the Framingham risk profile 
for coronary heart disease we have 
computed the relative risk, the 
absolute risk reduction and the 
number needed to be treated over 
6 years associated with modifying 
each of these risk factors, that is, 
reduction of systolic blood pres- 
sure to 120 mmHg, smoking ces- 
sation, normalisation of glucose 
intolerance and left ventricular 
hypertrophy. 
For each risk factor indicate in the 
last column of the table which pa- 
tient would benefit most from a 
risk factor modification. 
Treat in priority 
subject I or 2 
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